Oxycodone PR or high dose levodopa not effective against parkinsonian central pain, suggests study Jacinthlyn Sylvia8 July 2024 6:00 AM ISTA new study published in the journal of Movement Disorders found that neither oxycodone-prolonged release (PR) nor higher doses of...
Continuous subcutaneous levodopa-carbidopa infusion safe, effective for treating Parkinson's disease: Lancet Dr. Kamal Kant Kohli19 March 2024 8:00 PM ISTUSA: An international, multisite phase 3 trial published in The Lancet Neurology journal showed the safety and effectiveness of Parkinson's disease...
Submit Animal Toxicity Study Report: CDSCO Panel Tells Lupin on Parkinsonism FDC drug Dr. Divya Colin9 Feb 2024 6:00 PM ISTNew Delhi: Noting that the proposed dose is higher than the approved dose, the Subject Expert Committee (SEC) functional under the Central Drug...
Alembic Pharma Gets CDSCO Panel Nod to Study FDC Carbidopa, Levodopa ER Capsule for export purpose only Dr. Divya Colin14 Jan 2024 5:45 PM ISTNew Delhi: The drug major Alembic Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
USFDA rejects Amneal Pharma Parkinson's drug over safety concerns Ruchika Sharma6 July 2023 4:30 PM ISTThe agency has not identified efficacy or manufacturing issues with the treatment.
Levodopa Use Tied to Reduced Incidence of neovascular age-related macular degeneration Aditi1 Jun 2023 2:30 AM ISTPrevious studies have mentioned that Levodopa is tied to reduced development of new-onset neovascular age-related macular degeneration (nAMD).Data has...
Safinamide a safe and miraculous add-on therapy to Levodopa in Parkinson's disease Dr.Niharika Harsha B23 Nov 2022 8:00 PM ISTA new trial from China revealed that Safinamide has significantly reduced motor fluctuations, improved motor symptoms, and also the quality of life in...
Pramipexole and rasagiline combo first line treatment for parkinsons MD Editorial Team13 April 2022 9:45 AM ISTParkinson's disease (PD) is a brain disorder that leads to shaking, stiffness, and difficulty with walking, balance, and coordination. Parkinson's...
Levodopa-carbidopa intestinal gel decreases dyskinesia in patients with Parkinson's Disease: Study Medical Dialogues Editorial Team1 Feb 2022 9:00 AM ISTSpain: A new research discovered that levodopa-carbidopa intestinal gel (LCIG) dramatically decreased dyskinesia when compared to oral optimal medical...
Levodopa-Induced Dyskinesia in Parkinson's disease: Amantadine to Sheath the Double-edged Sword Dr. Nupur Rajoria31 Jan 2022 10:47 AM ISTParkinson's disease (PD) is a movement disorder and the second most common neurodegenerative disorder in adults over the age of 60 years (1). India is...
Genetically modified tomato an affordable source of Parkinson's disease drug: Study Dr. Kamal Kant Kohli10 Dec 2020 12:00 AM ISTScientists have produced a tomato enriched in the Parkinson's disease drug L-DOPA in what could become a new, affordable source of one of the world's...
Levodopa may improve vision in patients with macular degeneration Dr. Kamal Kant Kohli10 Sept 2020 8:02 PM ISTThe widely used and well-tolerated drug commonly used to treat Parkinson’s disease may help significantly reduce the need for more costly, more...
